Lungs News and Research

RSS

Researchers compare rhesus and cynomolgus macaques for SARS-CoV-2 vaccine trials

A team of researchers at the Biomedical Primate Research Centre based in the Netherlands have aimed to determine the effects of the SARS-CoV-2 pathogen on these monkeys and, subsequently, whether they make good animal models for future research in the area.

8 Nov 2020

Innate immunity key to limiting viral load in COVID-19 cases

As the coronavirus disease 2019 (COVID-19) pandemic continues to cause many difficulties for public health authorities, research is ongoing to understand how the virus can cause fatal effects on those infected and thereby suggest effective preventive and therapeutic measures against it.

8 Nov 2020

Study shows increasing size of respiratory droplets under cold humid conditions

Considerable evidence has accumulated to suggest that the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus may spread through prolonged or brief contact with infected patients - with the infection being spread through respiratory droplets and aerosols. The need to understand how these infectious droplets behave becomes ever more urgent. A recent study published in the preprint server medRxiv* in October 2020 reports the results of such an investigation.

8 Nov 2020

Black patients with lupus have higher risk of stroke and ischemic heart disease

New research reveals that, in the U.S., Black patients with lupus have a threefold higher risk of stroke and a 24-fold higher risk of ischemic heart disease.

6 Nov 2020

Lupus patients receiving prophylactic therapy are at high risk for adverse reactions

New research shows that adults with systemic lupus erythematosus, who receive trimethoprim-sulfamethoxazole (TMP-SMX), a prophylactic therapy to help prevent pneumocystis pneumonia, are at high risk for adverse reactions to the drug, particularly if they are also positive for anti-Smith (anti-Sm) antibodies.

6 Nov 2020

Patients with rheumatic diseases reported antimalarial drug shortages during COVID-19

A new study shows that patients with rheumatic diseases across Africa, Southeast Asia, the Americas and Europe had trouble filling their prescriptions of antimalarial drugs, including hydroxychloroquine, during the 2020 global coronavirus pandemic, when antimalarials were touted as a possible COVID-19 treatment.

6 Nov 2020

TB screening needed for people on methotrexate who live in at-risk areas

New research presented at ACR Convergence, the American College of Rheumatology's annual meeting, shows that tuberculosis (TB) screening and ongoing clinical care is needed for people on methotrexate who live in areas where the highly infectious illness is common.

6 Nov 2020

Women with interstitial lung disease may not need to terminate their pregnancies

A new study shows that women with interstitial lung disease (ILD) related to autoimmune disease may not need to terminate their pregnancies--despite the increased risk of adverse outcomes--provided they have close monitoring from their team of multidisciplinary physicians before, during and after pregnancy.

6 Nov 2020

How do low levels of oxygen damage the brain?

In this interview, Professor Paul Tesar and Kevin Allan speak to News-Medical about how low levels of oxygen damage the brain.

6 Nov 2020

Research describes novel molecules designed to treat or prevent COVID-19 infection

Neoleukin Therapeutics, Inc., "Neoleukin" (NASDAQ:NLTX), a biopharmaceutical company utilizing sophisticated computational methods to design de novo protein therapeutics, today announced the publication in Science of research describing novel molecules designed to treat or prevent infection by the virus that causes COVID-19, SARS-CoV-2.

6 Nov 2020

Persistent and extensive lung damage seen in COVID-19 patients

A team of researchers at the University of Trieste in Italy aimed to determine the extent and the causes of lung damage from COVID-19 to better understand the pathological correlates of the disease.

5 Nov 2020

Llama antibodies could be a potent nanoweapon against COVID-19

Today in Science, researchers at the University of Pittsburgh School of Medicine describe a new method to extract tiny but extremely powerful SARS-CoV-2 antibody fragments from llamas, which could be fashioned into inhalable therapeutics with the potential to prevent and treat COVID-19.

5 Nov 2020

Children produce different antibodies in response to infection with new coronavirus

Children and adults produce different types and amounts of antibodies in response to infection with the new coronavirus, SARS-CoV-2, a new study from researchers at Columbia University Vagelos College of Physicians and Surgeons has found.

5 Nov 2020

Researchers explore how different birth experience affect the developing nervous system

It is an experience we all share, as miraculous as it is mysterious. Birth. Today, roughly one in three births in the United States occurs via cesarean section or C-section.

5 Nov 2020

RNA-binding proteins may suppress antiviral defenses against SARS-CoV-2

Conducted by researchers in South Korea at the Institute for Basic Science and the International Vaccine Institute, a new study published on the preprint server bioRxiv in November 2020 describes the many host proteins that bind with the ribonucleic acid (RNA) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and regulate the replication of the virus.

4 Nov 2020

Researchers develop novel therapeutic approach against COPD

Chronic obstructive pulmonary disease (COPD) is one of the most common and deadliest diseases worldwide.

4 Nov 2020

Chikungunya can infect central nervous system and impair cognitive, motor functions

A study conducted by an international team of researchers with FAPESP's support shows that infection by chikungunya virus can produce even more severe manifestations than the typical symptoms of the disease, such as acute fever, headache, rash, and intense joint and muscle pain.

4 Nov 2020

Delirium accompanied by fever could be an early symptom of COVID-19

Delirium accompanied by fever could bean early symptom of COVID-19. This is the main conclusion drawn by a scientific research review carried out by researchers from the Universitat Oberta de Catalunya.

4 Nov 2020

‘Is this worth my life?’: Traveling health workers decry COVID care conditions

David Joel Perea called from Maine, Vermont, Minnesota and, ultimately, Nevada, always with the same request: "Mom, can you send tamales?" Dominga Perea would ship them overnight.

4 Nov 2020

Study sheds light on possible lung damage caused by COVID-19 virus

The study, published today in The Lancet's eBioMedicine, by King's College London in collaboration with University of Trieste and the International Centre for Genetic Engineering and Biology in Italy, shows the unique characteristics to the SARS-CoV-2 virus and may explain why patients suffer from 'long COVID'.

4 Nov 2020

Lungs News and Research

Researchers compare rhesus and cynomolgus macaques for SARS-CoV-2 vaccine trials

Innate immunity key to limiting viral load in COVID-19 cases

Study shows increasing size of respiratory droplets under cold humid conditions

Black patients with lupus have higher risk of stroke and ischemic heart disease

Lupus patients receiving prophylactic therapy are at high risk for adverse reactions

Patients with rheumatic diseases reported antimalarial drug shortages during COVID-19

TB screening needed for people on methotrexate who live in at-risk areas

Women with interstitial lung disease may not need to terminate their pregnancies

How do low levels of oxygen damage the brain?

Research describes novel molecules designed to treat or prevent COVID-19 infection

Persistent and extensive lung damage seen in COVID-19 patients

Llama antibodies could be a potent nanoweapon against COVID-19

Children produce different antibodies in response to infection with new coronavirus

Researchers explore how different birth experience affect the developing nervous system

RNA-binding proteins may suppress antiviral defenses against SARS-CoV-2

Researchers develop novel therapeutic approach against COPD

Chikungunya can infect central nervous system and impair cognitive, motor functions

Delirium accompanied by fever could be an early symptom of COVID-19

‘Is this worth my life?’: Traveling health workers decry COVID care conditions

Study sheds light on possible lung damage caused by COVID-19 virus

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Latest News